OpenVSafe by OpenVAERS
Search V-safe

7WU-33936-38830

3 vaccinations 2 coded responses 25 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
704 / LA
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-30
    Registered in v-safe
  3. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-19
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fever · None
    Adult check-in
  15. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-26
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-23
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-20
    Survey response — 3 months, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Breast MRI showed mild enlargement of lymph nodes in left Axilla and axillary tail which may be residual of vaccination received on same arm. Radiologist is recommending ultrasound of all axillary lymph nodes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-07-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-01-19
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-07-30
    Dose 3 — Pfizer-BioNTech
  28. 2022-10-29
    Survey response — 3 months, dose 3
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good
    Free text: Myeloperoxidase blood level extremely elevated- tested 10 after receiving Covid booster. History-normal myeloperoxidase past 2 years. No cardiac symptoms, chest pain or shortness of breath. Myeloperoxidase tested as part of employer wellness program.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2023-01-28
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-19Pfizer-BioNTech
32022-07-30Pfizer-BioNTech No

Free text

Release 7 — 3 months, dose 2

2021-04-20

Symptoms: Breast MRI showed mild enlargement of lymph nodes in left Axilla and axillary tail which may be residual of vaccination received on same arm. Radiologist is recommending ultrasound of all axillary lymph nodes.

Release 12 — 3 months, dose 3

2022-10-29

Symptoms: Myeloperoxidase blood level extremely elevated- tested 10 after receiving Covid booster. History-normal myeloperoxidase past 2 years. No cardiac symptoms, chest pain or shortness of breath. Myeloperoxidase tested as part of employer wellness program. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCondition aggravated · · ✓
SDLymphadenopathy ✓ ✓ ✓
SDPre-existing disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release